Nanobiotix S.A. (NASDAQ:NBTX – Get Free Report)’s stock price was up 3.6% during trading on Tuesday . The stock traded as high as $4.36 and last traded at $4.36. Approximately 10,235 shares traded hands during trading, a decline of 42% from the average daily volume of 17,666 shares. The stock had previously closed at $4.21.
Wall Street Analyst Weigh In
Separately, Guggenheim started coverage on shares of Nanobiotix in a research note on Wednesday, August 28th. They set a “buy” rating and a $12.00 target price for the company.
Check Out Our Latest Stock Analysis on NBTX
Nanobiotix Stock Up 3.6 %
About Nanobiotix
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Read More
- Five stocks we like better than Nanobiotix
- What is a Death Cross in Stocks?
- Palantir Cracks $50, Is There Still Time to Get on Board?
- What is the Australian Securities Exchange (ASX)
- Insider Buying Signals Upside for These 3 Stocks
- ESG Stocks, What Investors Should Know
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.
